Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Antengene Receives Regulatory Approval for XPOVIO® in Hong Kong
Monday, July 17, 2023Antengene Corporation has received approval from the Government of the Hong Kong Special Administrative Region HKSAR for their New Drug Application NDA of XPOVIO selinexor in combination with dexamethasone Xd
InnoCare Pharma Collaborates with ArriVent Biopharma
Friday, July 14, 2023InnoCare Pharma and ArriVent Biopharma have entered into a clinical development collaboration to assess the combination of two investigational drugs ICP and furmonertinib for the treatment of advanced nonsmall cell lung cancer NSCLC
Chugai Pharmaceutical, OMRON, and OMRON SINIC X Collaborate on Testing Human-Friendly Lab Automation System
Friday, July 14, 2023Chugai Pharmaceutical OMRON Corporation and OMRON SINIC X Corporation are collaborating to automate research processes in drug discovery The verification testing of the system is being carried out at Chugais research centre Chugai Life Science Park Y...
Astellas' Marketing Authorisation Application for Zolbetuximab Accepted by the European Medicines Agency
Friday, July 14, 2023Astellas Pharma has announced that the European Medicines Agency EMA has accepted the marketing authorisation application MAA for zolbetuximab
InnoCare Pharma Collaborates with ArriVent Biopharma
Friday, July 14, 2023InnoCare Pharma and ArriVent Biopharma have entered into a clinical development collaboration to assess the combination of two investigational drugs ICP and furmonertinib for the treatment of advanced nonsmall cell lung cancer NSCLC
FDA Accepts BeiGene's Supplemental New Drug Application for BRUKINSA® (Zanubrutinib)
Thursday, July 13, 2023BeiGene has announced that the US Food and Drug Administration FDA has accepted the supplemental new drug application sNDA for BRUKINSA zanubrutinib in combination with obinutuzumab for the treatment of adult patients with relapsed or refractory foll...
LianBio Announces Clinical Supply Agreement with AstraZeneca in China
Thursday, July 13, 2023The agreement aims to evaluate the safety and efficacy of BBP an investigational SHP inhibitor developed by LianBio and BridgeBio in combination with AstraZenecas osimertinib an epidermal growth factor receptor EGFR inhibitor
Biosyngen Receives US FDA Fast Track Designation for BRG01
Wednesday, July 12, 2023Biosyngens BRG therapy has received Fast Track Designation FTD from the US Food and Drug Administration FDA for the treatment of relapsedmetastatic nasopharyngeal carcinoma
Junshi Biosciences Announces Acceptance of the Supplemental New Drug Application for Toripalimab
Wednesday, July 12, 2023Shanghai Junshi Biosciences Junshi Biosciences has announced the submission of a supplemental new drug application for toripalimab their antiPD monoclonal antibody in combination with axitinib for the firstline treatment of patients with unresectable...
Avantor Expands Singapore Hub
Wednesday, July 12, 2023Avantor has expanded its Singapore hub which includes the addition of cGMP manufacturing facilities and a worldclass quality control laboratory to better serve the needs of customers in the Asia Middle East and Africa AMEA region
